Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DIVA test discovered to detect Johne's disease in goats
"This will support the use of vaccines as part of MAP control programs" - Professor Cath Rees.

Actiphage can differentiate between vaccinated and infected animals.

A new diagnostic test has shown potential to differentiate between vaccinated and infected animals with Johne's disease.

Previously, vaccination of livestock against Johne's disease, an infectious wasting condition affecting ruminants, has been hindered because there is no diagnostic test that can differentiate between vaccinated animals, and those with the disease (DIVA test). 

Researchers have discovered that the Actiphage blood test can differentiate between goats that are naturally infected with Johne's disease, and those with vaccinations. 

This discovery suggests potential for a vaccination programme to protect ruminants from the usually fatal disease. While previous tests to detect infection in vaccinated goats did not work, Actiphage detects live bacteria in a milk or blood sample. Because of this, the test is not affected by vaccination status. 

Professor Cath Rees, from the University of Nottingham, said: “We have now shown that Actiphage is compatible with a range of different methods for purifying white blood cells, demonstrating the versatility of our test and opening up a number of new applications.”

“This study provides evidence that Actiphage can also be used as a DIVA test, allowing us to differentiate between naturally infected and vaccinated animals; this will support the use of vaccines as part of MAP (Mycobacterium avium subspecies paratuberculosis) control programs.”

 

Image (C) PBD Biotech

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.